Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | MLX | Q9UH92 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 6/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.40 |
| ▸ | CALCRL | Q16602 | 3/20 | 0.39 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29411300 | 0.93 | ELANE (0.46) | XIAPMLXELANECMA1CALCRL | |
| SCHEMBL29566972 | 0.87 | XIAP (0.45) | XIAPMLXELANECMA1CALCRL | |
| SCHEMBL13567377 | 0.87 | XIAP (0.44) | XIAPMLXELANECMA1TAAR1 | |
| SCHEMBL29567397 | 0.87 | ELANE (0.50) | XIAPMLXELANECMA1TAAR1 | |
| SCHEMBL29567377 | 0.87 | XIAP (0.47) | XIAPMLXELANECMA1 | |
| SCHEMBL29567257 | 0.87 | XIAP (0.44) | XIAPMLXELANECMA1CAPN1 | |
| SCHEMBL11989026 | 0.86 | ELANE (0.44) | XIAPMLXELANECALCRLTAAR1 | |
| SCHEMBL29567754 | 0.86 | ELANE (0.48) | XIAPMLXELANECMA1TAAR1 | |
| SCHEMBL29567586 | 0.86 | XIAP (0.42) | XIAPMLXELANECMA1CALCRL | |
| SCHEMBL29567235 | 0.85 | NTSR1 (0.40) | ELANECAPN1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146274-A1 | RECOMBINANT SMALL-MOLECULE COLLAGEN, EXPRESSION SYSTEM THEREOF, AND PREPARATION METHOD THEREOF | JIANGSU TRAUTEC MEDICAL TECHNOLOGY CO., LTD. (CN) | 2026-05-28 | — | — | US | disclosed |
| EP-4703376-A1 | RECOMBINANT MICROMOLECULAR COLLAGEN, EXPRESSION SYSTEM THEREOF AND PREPARATION METHOD THEREFOR | JIANGSU TRAUTEC MEDICAL TECHNOLOGY CO., LTD. (CN) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024222324-A1 | RECOMBINANT MICROMOLECULAR COLLAGEN, EXPRESSION SYSTEM THEREOF AND PREPARATION METHOD THEREFOR | 江苏创健医疗科技股份有限公司 | 2024-10-31 | — | — | WO | disclosed |
| CN-116948013-B | Recombinant micromolecular collagen and expression system and preparation method thereof | 江苏创健医疗科技股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-116948013-A | Recombinant micromolecular collagen and expression system and preparation method thereof | 江苏创健医疗科技股份有限公司 | 2023-10-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146274-A1 | RECOMBINANT SMALL-MOLECULE COLLAGEN, EXPRESSION SYSTEM THEREOF, AND PREPARATION METHOD THEREOF | HM13, PHAX, SEC13 | XIAP 3061/4885MLX 82/4885ELANE 3885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.